Pre-Existing Immunity Predicts Response to First-Line Immunotherapy in Non-Small Cell Lung Cancer Patients.

Authors: Xagara, Anastasia, Goulielmaki, Maria, Fortis, Sotirios P., Kokkalis, Alexandros, Chantzara, Evangelia, Christodoulopoulos, George, Samaras, Ioannis, Saloustros, Emmanouil, Tsapakidis, Konstantinos, Papadopoulos, Vasileios, Pateras, Ioannis S., Georgoulias, Vasilis, Baxevanis, Constantin N., Kotsakis, Athanasios

Source: Cancers; Jul2024, Vol. 16 Issue 13, p2393, 14p

Subject Terms: IMMUNOPHENOTYPING, IN vitro studies, IMMUNOSUPPRESSIVE agents, RESEARCH funding, IMMUNOTHERAPY, ANTINEOPLASTIC agents, PROGRAMMED death-ligand 1, TUMOR markers, DESCRIPTIVE statistics, MYELOID-derived suppressor cells, IMMUNE checkpoint inhibitors, ANTIGENS, LUNG cancer, IMMUNITY, OVERALL survival

Prognostic Role of Circulating Tumor Cells in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Cabazitaxel: A Prospective Biomarker Study.

Authors: Koinis, Filippos, Zafeiriou, Zafeiris, Messaritakis, Ippokratis, Katsaounis, Panagiotis, Koumarianou, Anna, Kontopodis, Emmanouil, Chantzara, Evangelia, Aidarinis, Chrissovalantis, Lazarou, Alexandros, Christodoulopoulos, George, Emmanouilides, Christos, Hatzidaki, Dora, Kallergi, Galatea, Georgoulias, Vassilis, Kotsakis, Athanasios

Source: Cancers; Sep2023, Vol. 15 Issue 18, p4511, 16p

Subject Terms: CANCER patient psychology, BIOMARKERS, DRUG efficacy, RESEARCH, DISEASE progression, MULTIVARIATE analysis, METASTASIS, CABAZITAXEL, CASTRATION-resistant prostate cancer, DESCRIPTIVE statistics, FLUORESCENT antibody technique, RESEARCH funding, TRANSLATIONAL research, BODY fluid examination, LONGITUDINAL method, ALGORITHMS, PHENOTYPES

Emerging Role of YAP and the Hippo Pathway in Prostate Cancer.

Authors: Koinis, Filippos, Chantzara, Evangelia, Samarinas, Michael, Xagara, Anastasia, Kratiras, Zisis, Leontopoulou, Vasiliki, Kotsakis, Athanasios

Source: Biomedicines; Nov2022, Vol. 10 Issue 11, p2834, 18p

Subject Terms: HIPPO signaling pathway, PROSTATE cancer, YAP signaling proteins

Peripheral pre-existing cancer-antigen specific T-cell immunity as predictive biomarker for immunotherapy in NSCLC patients.

Authors: Xagara, Anastasia, Fortis, Sotirios P., Goulielmaki, Maria, Koinis, Filippos, Chantzara, Evangelia, Kokkalis, Alexandros, Samaras, Ioannis, Papadopoulos, Vasileios, Georgoulias, Vasileios, Baxevanis, Constantin N, Kotsakis, Athanasios

Source: Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, pe20504-e20504, 1p

Myeloid-Derived Suppressor Cells in Prostate Cancer: Present Knowledge and Future Perspectives.

Authors: Koinis, Filippos, Xagara, Anastasia, Chantzara, Evangelia, Leontopoulou, Vassiliki, Aidarinis, Chrissovalantis, Kotsakis, Athanasios

Source: Cells (2073-4409); Jan2022, Vol. 11 Issue 1, p20, 1p

Subject Terms: MYELOID-derived suppressor cells, PROSTATE cancer, CANCER cells, IMMUNE response, IMMUNE checkpoint proteins

Integrative analysis of circulating tumor cells (CTCs) and exosomes from small‐cell lung cancer (SCLC) patients: a comprehensive approach.

Authors: Papakonstantinou, Dimitrios¹ (AUTHOR), Roumeliotou, Argyro¹ (AUTHOR), Pantazaka, Evangelia¹ (AUTHOR), Shaukat, Athanasios‐Nasir² (AUTHOR), Christopoulou, Athina³ (AUTHOR), Koutras, Angelos⁴ (AUTHOR), Dimitrakopoulos, Foteinos‐Ioannis⁴ (AUTHOR), Georgoulias, Vassilis⁵ (AUTHOR), Xagara, Anastasia⁶ (AUTHOR), Chantzara, Evangelia⁶ (AUTHOR), Koinis, Fillipos⁶ (AUTHOR), Kotsakis, Athanasios⁶ (AUTHOR), Stathopoulos, Constantinos² (AUTHOR), Kallergi, Galatea¹ (AUTHOR) gkallergi@upatras.gr

Source: Molecular Oncology. Nov2024, p1. 18p. 7 Illustrations.

Subject Terms: *PROGRAMMED death-ligand 1, *TRANSCRIPTION factors, *PROGNOSIS, *CXCR4 receptors, *LUNG cancer, *CHEMOKINE receptors, *BREAST